Lowering the systolic blood pressure target in hypertensive patients: current controversies and future outlook
Randomized controlled trials and meta-analyses have established the benefits of blood pressure (BP) lowering. The 2017 American Heart Association/American College of Cardiology (AHA/ACC) guidelines for the management of hypertension established 130/80 mmHg as the threshold for the diagnosis- and tre...
Saved in:
Published in | Expert review of cardiovascular therapy Vol. 16; no. 12; p. 889 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
02.12.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Randomized controlled trials and meta-analyses have established the benefits of blood pressure (BP) lowering. The 2017 American Heart Association/American College of Cardiology (AHA/ACC) guidelines for the management of hypertension established 130/80 mmHg as the threshold for the diagnosis- and treatment-target BP level. Area covered: The global trends are thought to be heading toward intensive BP-lowering management. In this paper, authors summarize the evidence on lowering the BP target in hypertensive patients with a focus on the 2017 AHA/ACC guidelines. Expert commentary: According to the results of clinical research, meta-analyses and the 2017 AHA/ACC guidelines, the target systolic BP may change from less than 140/80 mmHg to 130/80 mmHg in any other international hypertension guidelines. However, this direction of intensive BP control is still controversial. |
---|---|
ISSN: | 1744-8344 |
DOI: | 10.1080/14779072.2018.1538784 |